Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm
- PMID: 16005406
- DOI: 10.1016/j.preteyeres.2005.01.001
Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm
Abstract
Macular exudative manifestations secondary to choroidal neovascular lesions remain the leading cause of definitive visual impairment and legal blindness in the elderly. During the past decade, advances in ophthalmic imaging systems have enabled the recognition of presumed new distinct choroidal neovascular lesions that share some unique clinical and angiographic peculiarities as well as better comprehension of the pathophysiologic mechanisms related to such entities. Amongst presumed newer exudative maculopathies, polypoidal choroidal vasculopathy, which has been described as a distinct choroidal abnormality characterized by inner choroidal vascular network of vessels ending in polyp-like structures only identified on indocyanine green angiography and mostly affecting African-American and Asian descendents, has gained special interest from the ophthalmic community particularly because of its growing recognition among patients with clinical appearance of neovascular age-related macular degeneration. Thus far, however, the exact nature of the vascular structure of the polypoidal choroidal vasculopathy lesion remains unclear and data from recent studies have conflicted with the initial concept of a benign exudative maculopathy with long-term preservation of good vision. All together, such factors make difficult the establishment of an appropriate treatment, if any, for the entity. Herein, by using a modified technique of conventional indocyanine green angiography, we demonstrate new information about the morphologic characteristics, and to some extent the blood flow dynamics perfusion, of the polypoidal choroidal vasculopathy lesion. Our results suggest that the PCV lesion should be considered a variety of choroidal neovascularization rather than a distinct clinical entity, characterized by one single large neovascular complex presenting well-defined arterial neovascular vessels arising from one major "ingrowth site" and draining vessels that present aneurysm-like dilations corresponding to the polyp-like structures typically described for the entity. Finally, the visual acuity and angiographic findings observed after selective ingrowth site photothrombosis corroborate the existence of one major "ingrowth site" for the PCV neovascular complex and point toward a new treatment paradigm for this variety of choroidal neovascularization.
Similar articles
-
[Polypoidal choroidal vasculopathy].Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):200-31; discussion 232. doi: 10.4264/numa.71.282. Nippon Ganka Gakkai Zasshi. 2012. PMID: 22568102 Review. Japanese.
-
Polypoidal choroidal vasculopathy.Surv Ophthalmol. 2004 Jan-Feb;49(1):25-37. doi: 10.1016/j.survophthal.2003.10.007. Surv Ophthalmol. 2004. PMID: 14711438 Review.
-
Polypoidal choroidal vasculopathy and treatments.Curr Opin Ophthalmol. 2008 May;19(3):208-12. doi: 10.1097/ICU.0b013e3282fb7c33. Curr Opin Ophthalmol. 2008. PMID: 18408495 Review.
-
Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.Am J Ophthalmol. 2012 May;153(5):910-922.e2. doi: 10.1016/j.ajo.2011.10.017. Epub 2012 Feb 4. Am J Ophthalmol. 2012. PMID: 22310077
-
Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.Am J Ophthalmol. 2010 Nov;150(5):666-73. doi: 10.1016/j.ajo.2010.05.035. Epub 2010 Aug 16. Am J Ophthalmol. 2010. PMID: 20719300
Cited by
-
A functional polymorphism in the promoter of αA-crystallin increases the risk of nAMD.Int J Clin Exp Pathol. 2019 May 1;12(5):1782-1787. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933998 Free PMC article.
-
Verteporfin PDT for non-standard indications--a review of current literature.Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):613-26. doi: 10.1007/s00417-010-1307-z. Epub 2010 Feb 17. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20162298 Review.
-
Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography.Br J Ophthalmol. 2007 Sep;91(9):1152-9. doi: 10.1136/bjo.2006.112318. Epub 2007 Feb 21. Br J Ophthalmol. 2007. PMID: 17314148 Free PMC article.
-
Prevalence of focal lamina cribrosa defects in eyes with pachychoroid disease spectrum.Int J Ophthalmol. 2022 Jan 18;15(1):77-82. doi: 10.18240/ijo.2022.01.12. eCollection 2022. Int J Ophthalmol. 2022. PMID: 35047360 Free PMC article.
-
Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.Clin Ophthalmol. 2012;6:1633-8. doi: 10.2147/OPTH.S37252. Epub 2012 Oct 8. Clin Ophthalmol. 2012. PMID: 23109800 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous